Zhu, Ming
Peng, Ruiqing
Liang, Xin
Lan, Zhengdao
Tang, Ming
Hou, Pingping
Song, Jian H.
Mak, Celia Sze Ling
Park, Jiwon
Zheng, Shui-er
Huang, Ailing
Ma, Xingdi
Chen, Ruidong
Chang, Qing
Logothetis, Christopher J.
Jain, Abhinav K.
Lin, Sue-Hwa http://orcid.org/0000-0002-6122-4054
Katayama, Hiroyuki
Hanash, Samir
Wang, Guocan http://orcid.org/0000-0002-8922-7249
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R00 CA194289, P50 CA140388)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 5 December 2020
Revised: 9 August 2021
Accepted: 20 August 2021
First Online: 1 September 2021
Competing interests
: CJL reports receiving commercial research grants from Bayer, Sanofi, Janssen, Astellas Pharma, Pfizer; and honoraria from Bayer, Janssen, Sanofi, Astellas Pharma. No potential conflicts of interest were disclosed by the other authors.